SJ

Saurabh Jerath

Active Director Director DIN 08929124
DIN 08929124 First appointment Oct 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2020
Shareholding value •••• Premium profile

About Saurabh Jerath

Data last updated:

Saurabh Jerath is a Director at Yamuna Pharmaceuticals Private Limited (since 2020). The company operates in Healthcare. Yamuna Pharmaceuticals Private Limited reported revenue of ₹2.6 Lakh (FY 2025).

DIN 08929124
Primary Designation Director
Industry Healthcare
First Appointment 21 Oct 2020
Oldest Company Age 6 yrs
Largest company Yamuna Pharmaceuticals Private Limited · ₹2.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Oct 20202020₹2.6 Lakh (FY 2025)Active

Board colleagues of Saurabh Jerath

NameDINCompanyDesignation
Tanmay Jerath08929123Yamuna Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Yamuna Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Saurabh Jerath

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saurabh Jerath

Saurabh Jerath currently holds 1 directorship: Yamuna Pharmaceuticals Private Limited (Director, since 21 Oct 2020, revenue ₹2.6 Lakh (FY 2025)).

Saurabh Jerath was first appointed on 21 Oct 2020 as Director at Yamuna Pharmaceuticals Private Limited.

The current boards of Saurabh Jerath's companies include Tanmay Jerath (Yamuna Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available